Auxxil

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Auxxil

Quick Facts

Property Description
Active Ingredient Levofloxacin
Forms Tablets, Oral Solution, Injection, Eye Drops
Pharmacological Class Fluoroquinolone Antibiotic
General Purpose To achieve bactericidal action against susceptible pathogens
Origin Synthetic (Chiral compound)

What Type of Medicine is Auxxil (Levofloxacin)?

Auxxil is a prescription-only medicine containing the synthetic chemical entity, Levofloxacin, as its active component. It is classified as an antibiotic and specifically belongs to the third-generation fluoroquinolone (FQ) class. Levofloxacin is the pure S-(-) isomer of ofloxacin, designated as an advanced, single-ingredient anti-infective agent. The classification as a third-generation fluoroquinolone is supported by pharmacological studies, acknowledging its enhanced spectrum compared to earlier fluoroquinolones. Levofloxacin is included on the Model List of Essential Medicines, underscoring its recognized importance for global public health.


What are the Active Ingredient and Forms of Auxxil?

The sole active ingredient in this medication is Levofloxacin, often present as the Levofloxacin hemihydrate. As a single-ingredient product, it is administered in various dosage forms to facilitate both systemic use and topical application. These forms include film-coated tablets for oral intake, an oral solution, a sterile solution for injection (IV infusion), and an ophthalmic solution (eye drops). The availability of both oral and intravenous formulations provides flexibility for treating serious bacterial infections, a feature for facilitating patient transitions. The product's diverse forms allow targeted treatment delivery, for instance, using the ophthalmic solution to treat bacterial conjunctivitis, a typical neutral use scenario.


What is the General Purpose of This Antibiotic?

The fundamental purpose of Auxxil is to achieve a definitive bactericidal action, thereby resolving underlying illnesses caused by bacterial infections. This goal is accomplished by Levofloxacin's selective interference with two critical bacterial enzymes, DNA gyrase and topoisomerase IV. As an established anti-infective agent with robust broad-spectrum activity, its primary therapeutic objective is the rapid and complete elimination of the bacterial population responsible for the illness.

Regulatory References

  1. WHO Essential Medicines List for Levofloxacin
  2. WHO Essential Medicines
  3. Levofloxacin Drug Information (NIH)

What side effects are possible with Auxxil?

Possible Side Effects and Safety Information

The safety profile of Auxxil (Levofloxacin), a fluoroquinolone antibiotic, is defined by adverse effects classified by frequency and body system in official regulatory documents. These effects range from common to potentially serious and irreversible.

Official Adverse Reaction Classification

Adverse reactions are formally grouped by regulatory authorities:

  • Common Reactions (ge1/100 to <1/10) typically include nausea, diarrhea, headache, insomnia, and dizziness, which are the most frequently observed effects in clinical use.
  • Uncommon Reactions (ge1/1,000 to <1/100) cover disturbances in gastrointestinal, musculoskeletal (e.g., arthralgia, myalgia), and psychiatric systems.
  • Rare Reactions (ge1/10,000 to <1/1,000) include more serious conditions like tendinitis and convulsion.

Serious and Time-Related Safety Concerns

The label documents serious adverse reactions that may be disabling, including tendon rupture, peripheral neuropathy, and significant Central Nervous System (CNS) effects (e.g., seizures, psychoses). These reactions may occur soon after starting treatment or up to several months after stopping the medicine. Other serious concerns include QT interval prolongation and the risk of aortic aneurysm and dissection.

Population-Specific Constraints

Safety notes are specified for certain groups: Older Adults (increased risk of tendon issues), patients with renal impairment (requires dose adjustment), and patients with Myasthenia Gravis (use is discouraged due to potential for exacerbation of muscle weakness). The medicine is generally contraindicated in pediatric patients due to documented musculoskeletal risks.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory documentation mandates that individuals must seek immediate medical attention upon suspected or actual overexposure to Auxxil (Levofloxacin). The official overdose profile is characterized by acute toxicological effects on the central nervous and cardiovascular systems.

Documented Overdose Manifestations and Outcomes

Physiological System Documented Manifestations
Central Nervous System (CNS) Acute confusion, dizziness, and the potential for convulsive seizures.
Cardiovascular System Prolongation of the QT interval on the ECG, carrying the risk of serious ventricular arrhythmias.

Official Emergency Management Statements

Management is strictly symptomatic and supportive, as official labels state that no specific antidote is known for Levofloxacin overdose. To reduce absorption following recent oral ingestion, emergency procedures like gastric lavage may be considered. Continuous patient observation and ECG monitoring are required due to the potential for severe cardiac toxicity. The effects of overdosage, including the risk of severe CNS manifestations, are exacerbated in patients with impaired renal function.

Therapeutic Uses of Auxxil

What Auxxil Treats: Main Uses and Benefits

Auxxil (Levofloxacin) is an antibiotic applied across several therapeutic domains to help address active bacterial infections. Its primary benefit is providing symptomatic relief, as it is used for managing the infectious process, and thus contributes to improved comfort and assists with maintaining functional stability during symptomatic periods.

This medication is commonly used across conditions presenting with acute episodes where bacteria cause significant symptomatic burden.


Auxxil is generally used for managing symptom clusters that may become intense or disruptive in conditions such as community-acquired pneumonia, severe sinusitis, acute exacerbations of chronic bronchitis, complicated urinary and renal tract infections like pyelonephritis, and conditions involving inflammatory or irritative processes of the skin and soft tissue. It is also relevant in specific clinical scenarios, including the post-exposure management of inhalational anthrax and plague. Applied in contexts marked by increased discomfort or tension, Auxxil may assist with easing the overall symptom load.

“This medication is relevant for managing symptoms that interfere with daily comfort in patients dealing with acute bacterial illnesses across key organ systems.”


Quick Fact: Symptom Relief Focus

Symptom Domain Description
Systemic Symptoms Helps address fever, chills, and generalized malaise.
Functional Strain Assists with easing difficulty breathing and painful urination.
Local Inflammation Supports the management of pronounced redness and swelling in skin infections.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Auxxil — official regulatory information

Auxxil (a fluoroquinolone-class antibiotic) is subject to strict usage criteria established by regulatory bodies.

Populations for whom use is contraindicated

  • Individuals with known hypersensitivity or severe allergic reactions to Auxxil or any other drug in the quinolone/fluoroquinolone class.
  • Patients who have experienced serious adverse reactions during prior fluoroquinolone use, including tendinitis or tendon rupture, peripheral neuropathy, or significant Central Nervous System (CNS) effects.

Eligibility-Related Restrictions and Special Considerations

Restriction Category Key Requirement/Condition
Reserved Use Must be reserved for patients with Acute Bacterial Sinusitis, Acute Bacterial Exacerbation of Chronic Bronchitis, or Uncomplicated Urinary Tract Infections only when no alternative treatment options are available.
Condition-Specific Avoid use in patients with a history of myasthenia gravis due to risk of exacerbation of muscle weakness.
Cardiac Avoid use in patients with known prolongation of the QT interval or other significant cardiac risks (e.g., uncorrected hypokalemia or hypomagnesemia).
Age/Impairment Dosage adjustment may be required for patients with renal impairment.

Connection to the overall eligibility profile: The regulatory profile for Auxxil strictly limits its use by mandating that patients who have experienced disabling side effects from a prior fluoroquinolone must not use it. Furthermore, its use for common infections is restricted to those who lack safer alternatives, emphasizing that the drug’s potential benefits must significantly outweigh its risks for any given patient.

What should I know about interactions with other medicines?

Auxxil Interactions with Other Medicines and Products

This section summarizes clinically significant drug and product interactions for Auxxil as documented in official regulatory labeling.

Auxxil's interaction profile is defined by its involvement in specific metabolic pathways and drug transporter systems. The concurrent use of Strong or Moderate CYP3A4 inhibitors may substantially increase the systemic exposure (AUC and C max) of Auxxil, potentially increasing its effects. Conversely, Strong CYP3A4 inducers may significantly decrease Auxxil's exposure, risking reduced efficacy. Transporter-mediated interactions are also documented, with Auxxil acting as an inhibitor of the OATP1B1 transporter, which can raise the concentration of co-administered OATP1B1 substrate drugs. Auxxil is also a substrate for P-glycoprotein (P-gp); P-gp inhibitors may increase Auxxil exposure.

Documented Interaction Constraints

Interaction Type Requirement/Restriction
Absorption Interference Do not take with multivalent cation-containing products (e.g., antacids, sucralfate); a specific time separation (e.g., 2 hours before or 4-8 hours after) is required to prevent reduced Auxxil absorption.
Pharmacodynamic Risk Increased risk of specific adverse events, such as tendon injury, when used concomitantly with corticosteroids; this risk may be more pronounced in the geriatric population.
Contraindicated Combinations Do not co-administer with medicinal products that significantly prolong the QT interval if Auxxil also causes QT prolongation.
Warfarin/Anticoagulants Requires increased monitoring of INR due to enhanced anticoagulant effect.

All patients must consult official prescribing information for a complete list of contraindicated and caution-required combinations.

Mechanism of Action

How Auxxil Works: Mechanism of Action

Auxxil (Levofloxacin) exerts its effect through the precise inhibition of two critical bacterial Type II topoisomerase enzymes: DNA gyrase and topoisomerase IV. Levofloxacin functions as an inhibitor, binding to the enzymes while they are engaged in breaking the bacterial DNA. This interaction traps the enzymes in their DNA-cleaved state, preventing the essential re-ligation of the DNA double-strand breaks.

This molecular blockade initiates a lethal mechanistic cascade. The resulting accumulation of DNA strand breaks stalls the bacterial replication fork and overwhelms the cell's repair pathways. The failure of critical cellular machinery results in the rapid, concentration-dependent cellular failure. This sequence defines the drug's definitive extbfbactericidal physiological effect.

Efficacy is constrained by bacterial factors, including extbfpoint mutations in the target enzyme genes ( gyrA/parC) that reduce Levofloxacin's binding affinity, and the presence of bacterial efflux pumps that actively reduce the intracellular drug concentration.

Dosage and Administration Information

How to Use Auxxil (Levofloxacin) — Official Administration Guidelines

Auxxil (Levofloxacin) is an antibiotic whose usage is governed by established administration instructions and dosage schedules. This medicine is administered via oral (tablets or solution), intravenous (IV) infusion, or ophthalmic routes.

Dosing and Frequency

Instruction Domain Official Guideline
Standard Dosing Adult systemic doses typically range from 250 mg to 750 mg per day. The regimen is typically dosed once daily.
Course Duration The duration of treatment is indication-specific, ranging from short courses of 3 days up to 60 days for certain post-exposure protocols.
Pediatric Dosing Pediatric patients (age 6 months or older) for certain severe infections use a weight-based dose (8 mg/kg) administered twice daily.

Preparation and Procedural Rules

Administration Rule Required Procedure
Timing with Food Tablets may be taken without regard to food. The Oral Solution should be consumed either 1 hour before or 2 hours after eating.
IV Infusion IV administration must be by slow infusion over at least 60 minutes (for 500 mg doses) or 90 minutes (for 750 mg doses); rapid IV injection is forbidden.
Renal Adjustment A mandatory dose adjustment (reduction and/or interval extension) is required for adult systemic use in patients with creatinine clearance less than 50 mL/min.

Missed Dose

If an oral dose is missed, take it as soon as it is remembered. However, if the time is near for the next scheduled dose, the missed dose should be skipped to prevent doubling the dosage.


The structure of this administration protocol defines the standardized framework for using the drug, mandating specific routes, once-daily adult frequency, and necessary dose adjustments to ensure proper application of the medicine.

Recent Clinical Evidence

Research evidence / Overview of studies for Auxxil (Levofloxacin)

Evidence for use in Community-Acquired Pneumonia and Sinusitis

Research exploring the use of Auxxil for bacterial infections of the lungs (Community-Acquired Pneumonia, or CAP) and sinuses (Acute Bacterial Sinusitis) primarily involves Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time, and they monitored patient outcomes related to both clinical outcome measures and microbiological eradication. Clinical outcome measures were based on observing outcomes related to the measurement of physical discomfort, such as fever, cough, and chest pain. The studies defined microbiological eradication as testing for the elimination of the specific bacteria causing the infection.

In these trials, researchers examined the use of Auxxil in adult patients with conditions characterized by fluctuating or episodic manifestations. The findings describe patterns observed in the studies related to the proportion of patients who provided data on the patterns of symptom evolution and clearance of the bacteria.

Evidence for use in Complicated Urinary Tract and Skin Infections

Studies have explored the use of Auxxil for specifically complicated infections of the urinary tract (cUTIs) and complicated skin and skin structure infections (cSSSIs). These trials were conducted during periods of increased symptom activity and used in research exploring both clinical outcome measures and microbiological eradication as key outcomes. The outcomes linked to inflammatory or irritative states and physiological strain were monitored.

Trials reported patterns related to the measurement of microbiological eradication of pathogens like E. coli in cUTIs. Comparative studies described measured responses that were used to explore patterns across different antibiotic regimens in the study populations.

Evidence for use in Unique Clinical Scenarios

The research for conditions like post-exposure management of inhalational anthrax and plague is based on very different research scenarios. Because human trials are neither feasible nor ethical for these rare, life-threatening conditions, the evidence for Auxxil’s use was derived from animal efficacy studies and Pharmacokinetic/Pharmacodynamic (PK/PD) modeling. This evidence contributes to the broader evidence landscape, although the evidence is limited as it is an extrapolation from animal models and not human RCTs.

Frequently Asked Questions (FAQ)

Common questions about Auxxil (FAQ)


Q: Are there any common foods or drinks that should be avoided while using Auxxil?

Regulatory documents indicate that the absorption of Auxxil may be reduced by food items containing multivalent cations, such as dairy products or calcium-fortified foods. Official advice specifies that while the tablets can be taken without regard to food, the oral solution should be consumed separately: one hour before or two hours after eating. Following this separation guideline may help optimize the absorption of the medication.


Q: Can Auxxil be used by people who have mild kidney problems?

Official administration guidelines describe that a mandatory dose adjustment (a reduction or interval extension) is typically necessary for adult patients who have moderate to severe renal impairment. This adjustment applies when creatinine clearance falls below 50 mL/min. Regulatory information indicates that specific dose adjustment based on kidney function is generally addressed for lower levels of renal clearance.


Q: How long does Auxxil stay in the system after the last use?

The half-life of Auxxil is approximately 6 to 8 hours, which is the time it takes for half of the medicine to be eliminated. Because the drug is mainly cleared through the kidneys, based on its half-life, the medicine is expected to take several days to be substantially cleared from the system.


Q: What does the official patient information leaflet say about Auxxil and alcohol?

Official documents do not typically provide explicit guidance on moderate alcohol consumption alongside Auxxil. However, both the medication and alcohol can cause Central Nervous System (CNS) effects, such as dizziness or lightheadedness. Official instructions advise caution with activities requiring mental alertness, particularly when used concurrently with substances that may worsen these CNS effects.


Q: Why do some people say they felt no change after using Auxxil?

The efficacy of Auxxil can be limited by specific bacterial factors. For instance, some bacteria can develop genetic changes that reduce the medicine's ability to bind to its targets, or they may possess mechanisms that actively pump the drug out of the bacterial cell. These factors are documented constraints that may reduce the drug’s intended bactericidal effect.


Q: Does Auxxil interact with birth control pills?

Official labels provide general warnings about the potential for interaction with other medicines that are metabolized through certain pathways or drug transporters. While the risk is general, a specific, widely published warning regarding a direct interaction with hormonal contraceptives is not typically found in the primary regulatory summaries.


Q: Does Auxxil affect the ability to drive or operate machinery?

Auxxil is associated with potential Central Nervous System (CNS) effects, including dizziness and lightheadedness. Official instructions state that due to these potential effects, engaging in activities that require mental alertness, such as driving or operating machinery, should be avoided until the individual understands how the medicine affects them.


Q: Is it possible to become dependent on Auxxil?

Official regulatory documents classify Auxxil as a prescription-only antibiotic. It is not listed as a controlled substance, and regulatory summaries do not include dependence or abuse potential in the warnings or adverse reactions sections of the product information.


Q: What is the difference between Auxxil and [similar drug name]? (No specific comparison needed)

Official classifications describe Auxxil as the pure S-(-) isomer of ofloxacin, and it belongs to the third-generation fluoroquinolone class of antibiotics. This classification places it within a defined category of anti-infective agents.


Q: Are there different versions or strengths of Auxxil available?

Auxxil is available in several forms, including film-coated tablets for oral intake, an oral solution, a sterile solution for intravenous infusion, and an ophthalmic solution (eye drops). For systemic use, the tablets are typically available in strengths of 250 mg, 500 mg, and 750 mg.


Q: How long is a typical course of treatment with Auxxil?

The duration of treatment is infection-specific, as described in regulatory documents. While treatment courses range from as short as 3 days up to 60 days for certain post-exposure protocols, common durations for many infections are typically between 5 and 14 days.


Q: Can Auxxil be safely used by older adults (e.g., people over 65)?

Official safety notes for older adults (those over 60 or 65) specify an increased risk for tendon issues, especially when the medicine is used at the same time as corticosteroids. This population may also have a higher susceptibility to the risk of QT interval prolongation, according to official information.


Q: Are there any known interactions between Auxxil and herbal supplements?

Regulatory guidance requires that patients inform their healthcare provider about all substances they are taking, including prescription and non-prescription medicines, vitamins, and all herbal and dietary supplements. This practice helps address the general potential for interactions that could affect the medication’s safety or effectiveness.


Q: Does Auxxil affect the results of common blood tests?

Official drug interaction information notes that Auxxil has the potential to cause false-positive results for opioids (opiates) in urine screening tests that use certain immunoassay methods. This potential effect is documented in the regulatory labeling.


Q: Are there any specific lifestyle changes mentioned in relation to using Auxxil?

Official patient counseling information advises caution regarding sun exposure. Because Auxxil can increase skin sensitivity (a condition known as photosensitivity), it is recommended to avoid sunlamps, tanning beds, and to limit time spent in the sun to help reduce the risk of severe sunburn, blistering, or swelling.


Q: Is it common to feel a little tired when first starting Auxxil?

Official documentation lists several common adverse reactions, including Insomnia and Dizziness. While specific fatigue is not a common listing, it is noted as a possible, though rare, sign of a more serious effect. Official information notes that signs of potential liver damage should be reported to a healthcare provider.


Q: What does it mean if the Auxxil package has a certain safety warning label?

The product is subject to a Boxed Warning, which represents a significant safety alert mandated by the FDA. This warning alerts patients and prescribers to the risk of serious, disabling, and potentially irreversible adverse reactions. These concerns include damage to tendons (tendinitis/tendon rupture), nerve damage (peripheral neuropathy), and Central Nervous System (CNS) effects.


Q: Does Auxxil cause dry mouth or frequent headaches?

Official adverse reaction data lists Headache as a common reaction associated with the use of Auxxil. However, Dry mouth is not generally listed among the commonly or uncommonly reported adverse reactions in the primary regulatory summaries.


Q: Does the time of day I use Auxxil matter for its effectiveness?

The adult dosage regimen for systemic use is typically prescribed to be taken once daily. Official instructions focus on ensuring the dosage is not accidentally doubled, but they do not specify a particular time of day for administration to maximize the overall effectiveness of the treatment.


Q: Do studies suggest that Auxxil helps improve quality of life?

Research evidence for Auxxil described in official documents primarily examines clinical outcome measures based on changes in physical symptoms and the microbiological eradication of the infection. Quality of life as a distinct, formal outcome measure is not a primary focus mentioned in the summarized evidence themes for the drug.


Q: Is it common to have changes in mood while using Auxxil?

Official documents list disturbances in the psychiatric systems as uncommon reactions (ge1/1,000 to <1/100). Serious but rare Central Nervous System (CNS) effects are also listed, including seizures and psychoses, which may involve changes in mood and behavior.


How should Auxxil be stored and disposed of?

How to Store and Dispose of Auxxil

Official Storage Conditions

Auxxil (Levofloxacin) tablets and oral solution must be stored at Controlled Room Temperature, which is maintained between 20 C and 25 C (68 F and 77 F). The medication must be kept in its original, tightly closed container and requires protection from light and moisture to ensure stability. Injection solutions must be specifically protected from freezing and excessive heat.

Child Safety and Disposal

It is an official requirement that Auxxil must be stored out of the sight and reach of children.

For disposal, unused or expired medication must be handled according to all applicable Federal, State, and local environmental regulations. It is necessary to follow established guidelines for the safe disposal of unused medicines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Auxxil found in:

A-Z Index: